Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
- Submitting institution
-
University of Southampton
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 52318394
- Type
- D - Journal article
- DOI
-
10.1038/s41591-019-0628-7
- Title of journal
- Nature Medicine
- Article number
- -
- First page
- 1706
- Volume
- 25
- Issue
- 11
- ISSN
- 1078-8956
- Open access status
- Exception within 3 months of publication
- Month of publication
- November
- Year of publication
- 2019
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
24
- Research group(s)
-
A - Cancer Sciences
- Citation count
- 72
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- I can confirm for 'a' that I made a substantial contribution to carrying out the study and for 'b' that I helped draft the output and to critique the output for important intellectual content.
- Non-English
- No
- English abstract
- -
